Search clinical trials for: VARIVAX

Total 88 results

Green Cross Corporation

Completed

Dose-escalation Phase 1 to Evaluate the Safety and Efficacy of MG1111 in Healthy Adults

Varicella (Chicken Pox)
Merck Sharp & Dohme LLC

Withdrawn

A Study to Evaluate the Immunogenicity, Safety, and Tolerability of VARIVAX™ Manufactured With a New Process (V210-062)

Varicella
Green Cross Corporation

Recruiting

Evaluate the Safety and Immunogenicity After MG1111(BARICELA Inj.) as 2nd Vaccination in 4 ~ 6 Year Old Healthy Children With a History of 1st Varicella Vaccination

Varicella

Korea, Republic of
Merck Sharp & Dohme LLC

Completed

Evaluation of Immunogenicity and Safety of VARIVAX™ New Seed Process (NSP) in Children (V210-063)

Varicella
SK Chemicals Co., Ltd.

Completed

The Evaluation of Immunogenicity and Safety of NBP608 in Healthy Children 12 Months to 12 Years of Age

Varicella

Philippines
SK Bioscience Co., Ltd.

Completed

Immunogenicity and Safety of NBP608 Compared to Varivax in Healthy Children 12 Months to 12 Years of Age

Varicella

Philippines
Merck Sharp & Dohme LLC

Completed

Re-examination Study For Varivax (V210-059 AM2)

Varicella
Merck Sharp & Dohme LLC

Completed

Evaluation of Immunogenicity and Safety of VARIVAX® Passage Extension 34 (PE34) Process in Children (V210-A03)

Varicella

United States
Merck Sharp & Dohme LLC

Completed

Evaluation of the Immunogenicity and Safety of VARIVAX™ in Healthy Russians (V210-058)

Varicella

Russian Federation
Merck Sharp & Dohme LLC

Completed

Safety Study of a Refrigerator-stable Formulation of VARIVAX®

Measles | Rubella | Mumps | Varicella

France, Italy
Sinovac (Dalian) Vaccine Technology Co., Ltd.

Enrolling by invitation

Immunogenicity and Safety of Varicella Vaccine, Live in Healthy Children Aged 12~15 Months in the Philippines

Varicella

Philippines
University of Colorado, Denver
Centers for Disease Control and Prevention

Withdrawn

Persistence of Varicella Immunity in Hospital Employees Receiving Varicella Vaccine

Persistence of Varicella Immunity

United States
The Hospital for Sick Children

Completed

The Safety of Oka Varicella in Children Prior to Solid Organ Transplantation

Organ Transplantation | Immunosuppression

Canada
National Institute of Allergy and Infectious Diseases...

Terminated

Immune Responses to Two Dose Varivax +/- MMR-II

Measles | Rubella | Mumps | Varicella

United States
SK Chemicals Co., Ltd.

Completed

Safety Study of NBP608 in Healthy Adult Volunteers

Immunization; Infection | Varicella Zoster

Korea, Republic of
GlaxoSmithKline

Completed

Immunogenicity & Safety of Hepatitis A Vaccine Co-admin With a Measles/Mumps/Rubella & a Varicella Vaccine in Children

Hepatitis A

United States
Merck Sharp & Dohme LLC

Completed

Immunogenicity and Safety of Concomitant Administration of MMR™ rHA and VARIVAX® by Intramuscular Versus Subcutaneous Route (V205C-011)

Measles | Mumps | Varicella

France, Germany
GlaxoSmithKline

Completed

Immunogenicity and Safety of Kinrix + (Measles Mumps Rubella) MMR Vaccine With and Without Varicella Vaccine in Healthy Children 4-6 Years

Tetanus | Diphtheria | Acellular Pertussis

United States
Santéclair

Completed

The VEPRO Trial: A Cross-Over Randomised Controlled Trial Comparing 2 Corrective Lenses for Patients With Presbyopia (VEPRO)

Presbyopia

France
Xinqiao Hospital of Chongqing

Completed

3DV+TPS Applied to Radiotherapy for Nasopharyngeal Carcinoma

Nasopharynx Cancer | Radiotherapy

China
Varian, a Siemens Healthineers Company
Rigshospitalet, Denmark; Herlev Hospital

Recruiting

Conventionally Fractionated Adaptive Radiation Therapy of Bladder Cancer an Individualized Approach (ARTIA-Vesica)

Muscle-Invasive Bladder Carcinoma

Denmark
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, and Immunogenicity of 3 Frozen ProQuad Consistency Lots in Healthy Children (V221-012)(COMPLETED)

Measles | Rubella | Mumps | Varicella
Varian, a Siemens Healthineers Company

Recruiting

Daily Adaptive Radiation Therapy an Individualized Approach for Carcinoma of the Cervix (ARTIA-Cervix)

Cervical Cancer by FIGO Stage 2018

United States
Xinqiao Hospital of Chongqing

Completed

3DV+TPS Software Outlines the Radiotherapy of Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma | Radiotherapy

China
Vietnam Military Medical University
Vabiotech

Completed

Safety and Immunogenicity of the Inactivated Rabies Vaccine RABIVAX-S Administered Intramuscularly and Intradermally

Rabies

Vietnam
Ross University School of Veterinary Medicine
Serum Institute of India Pvt. Ltd.

Completed

Safety of Rabivax-S for Pre-exposure Prophylaxis

Rabies Vaccine Adverse Reaction

Saint Kitts and Nevis
University of Castilla-La Mancha
Centro de Salud Talavera Centro y Centro de Salud La Algodonera.; Clínica Radiodiagnóstico... and other collaborators

Completed

Magnetotherapy Versus Microwave Combined With Exercise for Knee Osteoarthritis. (MT-MW-EX)

Pain | Knee Osteoarthritis

Spain
Star Scientific, Inc

Completed

A Pilot Study to Evaluate the Efficacy and Safety of Ariva® Silver Wintergreen in Healthy Smokers

Smoking | Tobacco Use Disorder

United States
Malaria Vaccine and Drug Development Center
Ministerio de la Protección Social, Colombia.

Completed

Establishment of a Sporozoite Challenge Model for Plasmodium Vivax in Human Volunteers (ChallengeII)

Malaria, Vivax

Colombia
Merck Sharp & Dohme LLC

Completed

ProQuad™ Versus M-M-R II™ and VARIVAX™ in Healthy Children (V221-009)(COMPLETED)

Measles | Rubella | Mumps | Varicella
Merck Sharp & Dohme LLC

Terminated

A Study of ProQuad™ in Healthy Children in Korea (V221-023)

Measles | Rubella | Mumps | Varicella
Varian, a Siemens Healthineers Company

Recruiting

Cardiac RADIoablation Versus Repeat Catheter Ablation: a Pivotal Randomized Clinical Trial Evaluating Safety and Efficacy for Patients With High-risk Refractory Ventricular Tachycardia (RADIATE-VT) (RADIATE-VT)

Tachycardia, Ventricular

United States
Merck Sharp & Dohme LLC

Completed

A Study of ProQuad in Healthy 4 to 6 Year Old Children (V221-014)

Measles | Rubella | Mumps | Varicella
Merck Sharp & Dohme LLC

Completed

Frozen ProQuad Administered Concomitantly Versus Nonconcomitantly With Other Pediatric Vaccines

Measles | Rubella | Mumps | Varicella
Herlev Hospital

Recruiting

Re-optimization Based Online Adaptive Radiotherapy of Anal Cancer (ROAR-A)

Anal Squamous Cell Carcinoma | Anal Cancer | Anal Carcinoma

Denmark
Ross University School of Veterinary Medicine
Serum Institute of India Pvt. Ltd.

Completed

Non-specific Effects of Rabies Vaccine

Diarrhea | Fever | Influenza-like Illness | Upper Respiratory Disease

Saint Kitts and Nevis
University of Texas Southwestern Medical Center

Completed

Phase 1B Study of RiVax, a Vaccine to Prevent the Toxic Effects of Ricin (FDA-OPD)

Healthy

United States
NYU Langone Health

Completed

The Effects of Cold Liquids on the Swallowing Mechanism in Preterm Infants

Dysphagia

United States
University Hospital, Essen

Recruiting

Lung_Cancer_adaptive - Ethos

Lung Cancer

Germany
National Institute of Allergy and Infectious Diseases...
Merck Sharp & Dohme LLC; Cooperative Clinical Trials in Pediatric Transplantation and other collaborators

Terminated

Evaluation of the Safety of Varivax® in Pediatric Renal Transplant Recipients

Kidney Transplant Recipients

United States
NYU Langone Health

Completed

Effect of Nasal Continuous Positive Airway Pressure on The Pharyngeal Swallow in Neonates

Respiratory Aspiration | Deglutition Disorders | Respiratory Distress Syndrome In Premature Infants | Newborn, Premature
GlaxoSmithKline

Completed

An Efficacy Study of GlaxoSmithKline (GSK) Biologicals' Candidate Influenza Vaccine GSK2321138A in Children

Influenza

Spain, Poland, Philippines, Thailand, Belgium, United Kingdom, Czechia, Bangladesh, Dominican Republic, Honduras, Lebanon, Turkey, India
British Columbia Cancer Agency

Completed

High Dose Rate Prostate Brachytherapy: Dose Escalation to Dominant Intra-prostatic Nodule (Dosepainting)

Prostate Cancer

Canada
University of Oxford

Active, not recruiting

VAC069: A Study of Blood-stage Controlled Human P. Vivax Infection

Malaria, Vivax

United Kingdom
GlaxoSmithKline

Completed

Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of Age

Measles | Rubella | Mumps | Measles-Mumps-Rubella Vaccine

United States, Puerto Rico
Washington University School of Medicine
Children's Discovery Institute

Not yet recruiting

Neoepitope-based Personalized DNA Vaccine Approach in Pediatric Patients With Recurrent Brain Tumors

Pediatric Recurrent Brain Tumor

United States
U.S. Army Medical Research and Development Command
GlaxoSmithKline; United States Department of Defense; Walter Reed Army Institute... and other collaborators

Completed

Study of VMP001 and AS01B (Adjuvant Formulation) in Healthy Malaria-Naïve Adults

Malaria | Plasmodium Vivax

United States
Socrates Herrera Valencia

Completed

Exposure of Naive and Pre-immune Subjects to P. Vivax Challenge (ChallengeIII)

Malaria

Colombia
GlaxoSmithKline

Completed

Consistency Study of GlaxoSmithKline (GSK) Biologicals' MMR Vaccine (209762) (Priorix) Comparing Immunogenicity and Safety to Merck & Co., Inc.'s MMR Vaccine (M-M-R II), in Children 12 to 15 Months of Age

Measles | Rubella | Mumps

United States, Finland, Estonia, Spain, Mexico, Puerto Rico
Merck Sharp & Dohme LLC

Completed

A Study of An Approved Vaccine at Mumps Expiry Potency in Healthy Children 12 to 18 Months of Age (V205C-007)(COMPLETED)

Measles | Rubella | Mumps | Varicella

Search clinical trials for: VARIVAX

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Vietnam

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations